Mortality from ischaemic heart disease: Sex-specific effects of transferrin saturation, serum iron, and total iron binding capacity. the HUNT study

European Journal of Cardiovascular Prevention and Rehabilitation

Volumn 18, Issue 5, 2011, Pages 687-694

  Mørkedal, Bjørn ^a   Laugsand, Lars E ^a   Romundstad, Pal R ^a   Vatten, Lars J ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Ischaemic heart disease; Serum iron; Sex; Total iron binding capacity; Transferrin saturation

Indexed keywords

IRON; TRANSFERRIN;

ADULT; ARTICLE; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HAZARD RATIO; HEART INFARCTION; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SEX DIFFERENCE; STROKE;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; IRON; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NORWAY; ODDS RATIO; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TIME FACTORS; TRANSFERRIN;

EID: 80054858892     PISSN: 17418267     EISSN: 17418275     Source Type: Journal    
DOI: 10.1177/1741826710390134     Document Type: Article

References (33)

1. Sullivan J. Iron and the sex difference in heart disease risk. Lancet 1981; 1(8233): 1293.
2. Giles WH. Iron and ischemic heart disease. Circulation 1993; 87(6): 2065.
3. Baer D, Tekawa I and Hurley L. Iron stores are not asso-ciated with acute myocardial infarction. Circulation 1994; 89(6): 2915-2918. (Pubitemid 24173715)
4. Liao Y, Cooper R and Mc Gee D. Iron status and coro-nary heart disease: negative findings from the NHANES I epidemiologic follow-up study. Am J Epidemiol 1994; 139(7): 704-712. (Pubitemid 24121279)
5. Asperen I, Feskens E, Bowles C and Kromhout D. Body iron stores and mortality due to cancer and ischaemic heart disease: a 17-year follow-up study of elderly men and women. Int J Epidemiol 1995; 24(4): 665-670.
6. Reunanen A, Takkunen H, Knekt P, Seppanen R and Aromaa A. Body iron stores, dietary iron intake and cor-onary heart disease mortality. J Intern Med 1995; 238(3): 223-230.
7. van der A DL, Marx JJM, Grobbee DE, Kamphuis MH, Georgiou NA, van Kats-Renaud JH, et al. Non-transferrin-bound iron and risk of coronary heart disease in postmenopausal women. Circulation 2006; 113(16): 1942-1949.
8. Sempos C, Looker A, Gillum R and Makuc D. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994; 330(16): 1119-1124. (Pubitemid 24118269)
9. Morrison H, Semenciw R, Mao Y and Wigle D. Serum iron and risk of fatal acute myocardial infarction. Epidemiology 1994; 5(2): 243-246. (Pubitemid 24073399)
10. Corti M, Guralnik J, Salive M, Ferrucci L, Pahor M, Wallace R, et al. Serum iron level, coronary artery dis-ease, and all-cause mortality in older men and women. Am J Cardiol 1997; 79(2): 120.
11. Magnusson M, Sigfusson N, Sigvaldason H, Johannesson G, Magnusson S and Thorgeirsson G. Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 1994; 89(1): 102-108. (Pubitemid 24026478)
12. Klipstein-Grobusch K, Koster J, Grobbee D, Lindemans J, Boeing H, Hofman A, et al. Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam Study. Am J Clin Nutr 1999; 69(6): 1231-1236. (Pubitemid 29252058)
13. Danesh J and Appleby P. Coronary heart disease and iron status meta-analyses of prospective studies. Circulation 1999; 99(7): 852-854. (Pubitemid 29094295)
14. Weiss G and Goodnough LT. Anemia ofchronic disease. N Engl J Med 2005; 352: 1011-1023.
15. Holmen J, Midthjell K, Kruger Ø, Langhammer A, Holmen T, Bratberg G, et al. The Nord-Trøndelag Health Study 1995-97 (HUNT 2): objectives, contents, methods and participation. Norsk Epidemiologi 2003; 13(1): 19-32.
16. Asberg A, Hveem K, Thorstensen K, Ellekjaer E, Kannelonning K, Fjosne U, et al. Screening for hemo-chromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol2001; 36(10): 1108.
17. Durham LK. Comparison of two smoothingmethods for exploring waning vaccine effects. Journal of the Royal Statistical Society 1999; 48(3): 395-407.
18. Fox C, Cullen D, Knuiman M, Cumpston G, Divitini M, Rossi E, et al. Effects ofbody iron stores and haemochro-matosis genotypes on coronary heart disease outcomes in the Busselton health study. J Cardiovasc Risk 2002; 9(5): 287.
19. Gupta A and Abbi A. High serum transferrin receptor level in anemia of chronic disorders indicates coexistent iron deficiency. Am J Hematol 2003; 72(3): 158.
20. Nemeth E. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004; 113(9): 1271.
21. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999; 341: 1986-1995. (Pubitemid 30010408)
22. Shoenfeld Y, Gerli R, Doria A, Matsuura E, Cerinic MM, Ronda N, et al. Accelerated atherosclerosis in auto-immune rheumatic diseases. Circulation 2005; 112(21): 3337-3347. (Pubitemid 43739380)
23. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epi-demiology and prevention. Circulation 2003; 108(17): 2154-2169. (Pubitemid 37337595)
24. Sarnak MJ, Tighiouart H, Manjunath G, Mac Leod B, Griffith J, Salem D, et al. Anemia as a risk factor for cardiovascular disease in the atherosclerosis risk in com-munities (ARIC) study. J Am Coll Cardiol 2002; 40(1): 27-33. (Pubitemid 34701373)
25. Olsen MH, Wachtell K, Beevers G, Dahlof B, Devereux RB, de Faire U, et al. Prognostic importance of hemo-globin in hypertensive patients with electrocardiographic left ventricular hypertrophy: The Losartan Intervention For End point reduction in hypertension (LIFE) study. Am Heart J2009; 157(1): 177-184.
26. Sharma S, Gage BF, Deych E and Rich MW. Anemia: An independent predictor of death and hospitalizations among elderly patients with atrial fibrillation. Am Heart J 2009; 157(6): 1057-1063.
27. Muzzarelli S and Pfisterer M. Anemia as independent predictor of major events in elderly patients with chronic angina. Am Heart J2006; 152(5): 991-996. (Pubitemid 44632950)
28. Lipsic E, van der Horst ICC, Voors AA, van der Meer P, Nijsten MWN, van Gilst WH, et al. Hemoglobin levels and 30-day mortality in patients after myocardial infarction. Int J Cardiol 2005; 100(2): 289-292.
29. Mc Kechnie RS, Smith D, Montoye C, Kline-Rogers E, O'Donnell MJ, De Franco AC, et al. Prognostic implica-tion of anemia on in-hospital outcomes after percutane-ous coronary intervention. Circulation 2004; 110(3): 271-277. (Pubitemid 38955496)
30. Vaglio J, Safley DM, Rahman M, Kosiborod M, Jones P, Thompson R, et al. Relation of anemia at discharge to survival after acute coronary syndromes. Am J Cardiol 2005; 96(4): 496-499. (Pubitemid 41132763)
31. Horwich TB, Fonarow GC, Hamilton MA, Mac Lellan WR and Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002; 39(11): 1780-1786. (Pubitemid 34595288)
32. Anand I, Mc Murray JJV, Whitmore J, Warren M, Pham A, Mc Camish MA, et al. Anemia and its relationship to clinical outcome in heart failure. Circulation 2004; 110(2): 149-154. 33. (Pubitemid 38924582)
33. Grundtvig M, Hagen TP, German M and Reikvam A. Sex-based differences in premature first myocardial infarction caused by smoking: twice as many years lost by women as by men. Eur J Cardiovasc Prev Rehabil 2009; 16(2): 174-179.